Increased CD86 but Not CD80 and PD-L1 expression on liver CD68+ cells during chronic HBV infection

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Said, Elias A ^a   Al Reesi, Iman ^a   Al Riyami, Marwa ^a   Al Naamani, Khalid ^b   Al Sinawi, Shadia ^a   Al Balushi, Mohammed S ^a   Koh, Crystal Y ^a   Al Busaidi, Juma Z ^a   Idris, Mohamed A ^a   Al Jabri, Ali A ^a  

^a SULTAN QABOOS UNIVERSITY   (Oman)

^b Armed Forces Hospital   (Oman)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; B7 ANTIGEN; CD86 ANTIGEN; PD L1 ANTIGEN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; PROGRAMMED DEATH 1 LIGAND 1;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CD68+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER FIBROSIS; LIVER LOBULE; LYMPHOCYTE COUNT; MALE; T LYMPHOCYTE; UPREGULATION; VIRUS LOAD; BIOPSY; CASE CONTROL STUDY; CELL COUNT; CHRONIC HEPATITIS B; FIBROSIS; LIVER; METABOLISM; MIDDLE AGED; PATHOLOGY; VIROLOGY; YOUNG ADULT;

ADULT; ANTIGENS, CD; ANTIGENS, CD274; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOMARKERS; BIOPSY; CASE-CONTROL STUDIES; CELL COUNT; FEMALE; FIBROSIS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; MALE; MIDDLE AGED; VIRAL LOAD; YOUNG ADULT;

EID: 84977177792     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0158265     Document Type: Article

References (50)

1. WHO MC (2015) Hepatitis B. WHO, World Health Organization.
2. Bertoletti A, Gehring AJ (2006) The immune response during hepatitis B virus infection. Journal of General Virology 87: 1439-1449. PMID: 16690908
3. den Brouw MLO, Binda RS, van Roosmalen MH, Protzer U, Janssen HLA, van der Molen RG, et al. (2009) Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus. Immunology 126: 280-289. doi: 10.1111/j.1365-2567.2008.02896.x PMID: 18624732
4. Peng GP, Li SP, Wu W, Tan XF, Chen YQ, Chen Z (2008) PD-1 upregulation is associated with HBV specific T cell dysfunction in chronic hepatitis B patients. Molecular Immunology 45: 963-970. PMID: 17868872
5. Boonstra A, Woltman AM, Janssen HLA (2008) Immunology of hepatitis B and hepatitis C virus infections. Best Practice & Research in Clinical Gastroenterology 22: 1049-1061.
6. Schmidt J, Blum HE, Thimme R (2013) T-cell responses in hepatitis B and C virus infection: similarities and differences. Emerging Microbes & Infections 2.
7. Boltjes A, Movita D, Boonstra A, Woltman AM (2014) The role of Kupffer cells in hepatitis B and hepatitis C virus infections. Journal of Hepatology 61: 660-671. doi: 10.1016/j.jhep.2014.04.026 PMID: 24798624
8. Romo-Tena J, Gomez-Martin D, Alcocer-Varela J (2013) CTLA-4 and autoimmunity: New insights into the dual regulator of tolerance. Autoimmunity Reviews 12: 1171-1176. doi: 10.1016/j.autrev.2013.07.002 PMID: 23851140
9. Manzotti CN, Liu MXP, Burke F, Dussably L, Zheng Y, Sansom DM (2006) Integration of CD28 and CTLA-4 function results in differential responses of T cells to CD80 and CD86. European Journal of Immunology 36: 1413-1422. PMID: 16708397
10. Sansom DM (2000) CD28, CTLA-4 and their ligands: who does what and to whom? Immunology 101: 169-177. PMID: 11012769
11. Zhang Q, Wang HY, Wei F, Liu XB, Paterson JC, Roy D, et al. (2014) Cutaneous T Cell Lymphoma Expresses Immunosuppressive CD80 (B7-1) Cell Surface Protein in a STAT5-Dependent Manner. Journal of Immunology 192: 2913-2919.
12. Asai-Tajiri Y, Matsumoto K, Fukuyama S, Kan-o K, Nakano T, Tonai K, et al. (2014) Small interfering RNA against CD86 during allergen challenge blocks experimental allergic asthma. Respiratory Research 15.
13. Balkhi MY, Latchumanan VK, Singh B, Sharma P, Natarajan K (2004) Cross-regulation of CD86 by CD80 differentially regulates T helper responses from Mycobacterium tuberculosis secretory antigen-activated dendritic cell subsets. Journal of Leukocyte Biology 75: 874-883. PMID: 14966193
14. Maj T, Slawek A, Chelmonska-Soyta A (2014) CD80 and CD86 Costimulatory Molecules Differentially Regulate OT-II CD4(+) T Lymphocyte Proliferation and Cytokine Response in Cocultures with Antigen-Presenting Cells Derived from Pregnant and Pseudopregnant Mice. Mediators of Inflammation.
15. Slavik JM, Hutchcroft JE, Bierer BE (1999) CD28/CTLA-4 and CD80/CD86 families - Signaling and function. Immunologic Research 19: 1-24. PMID: 10374692
16. Yoshida T, Hachimura S, Ishimori M, Ise W, Totsuka M, Ametani A, et al. (2003) Interleukin 12 and CD86 regulate Th1 and Th2 development induced by a range of antigen doses presented by Peyer's patch and spleen cells. Cytotechnology 43: 81-88. doi: 10.1023/B PMID: 19003211
17. Bertoletti A, DElios MM, Boni C, DeCarli M, Zignego AL, Durazzo M, et al. (1997) Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology 112: 193-199. PMID: 8978359
18. Chang JJ, Thompson AJV, Visvanathan K, Kent SJ, Cameron PU, Wightman F, et al. (2007) The phenotype of hepatitis B virus-specific T cells differ in the liver and blood in chronic hepatitis B virus infection. Hepatology 46: 1332-1340. PMID: 17924445
19. Said EA, Dupuy FP, Trautmann L, Zhang YW, Shi Y, El-Far M, et al. (2010) Programmed death-1-induced interleukin-10 production by monocytes impairs CD4(+) T cell activation during HIV infection. Nature Medicine 16: 452-U136. doi: 10.1038/nm.2106 PMID: 20208540
20. Carter LL, Fouser LA, Jussif J, Fitz L, Deng B, Wood CR, et al. (2002) PD-1: PD-L inhibitory pathway affects both CD4(+)and CD8(+) T cells and is overcome by IL-2. European Journal of Immunology 32: 634-643. PMID: 11857337
21. Trautmann L, Said EA, Halwani R, Janbazian L, Chomont N, El-Far M, et al. (2007) Programmed death 1: a critical regulator of T-cell function and a strong target for immunotherapies for chronic viral infections. Current Opinion in Hiv and Aids 2: 219-227. doi: 10.1097/COH.0b013e3280ebb5c9 PMID: 19372890
22. Leifeld L, Trautwein C, Dumoulin FL, Manns MP, Sauerbruch T, Spengler U (1999) Enhanced expression of CD80 (B7-1), CD86 (B7-2), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure. American Journal of Pathology 154: 1711-1720. PMID: 10362796
23. Chen J, Wang XM, Wu XJ, Wang Y, Zhao H, Shen B, et al. (2011) Intrahepatic levels of PD-1/PD-L correlate with liver inflammation in chronic hepatitis B. Inflammation Research 60: 47-53. doi: 10.1007/s00011-010-0233-1 PMID: 20661763
24. Kassel R, Cruise MW, Iezzoni JC, Taylor NA, Pruett TL, Hahn YS (2009) Chronically Inflamed Livers Up-Regulate Expression of Inhibitory B7 Family Members. Hepatology 50: 1625-1637. doi: 10.1002/hep.23173 PMID: 19739236
25. Wang BJ, Bao JJ, Wang JZ, Wang Y, Jiang M, Xing MY, et al. (2011) Immunostaining of PD-1/PD-Ls in liver tissues of patients with hepatitis and hepatocellular carcinoma. World Journal of Gastroenterology 17: 3322-3329. doi: 10.3748/wjg.v17.i28.3322 PMID: 21876620
26. Zhang WJ, Peng CH, Wan YL, Lateef SA, Zheng SS (2012) Longitudinal fluctuations in PD1 and PD-L1 expression in association with changes in anti-viral immune response in chronic hepatitis B. Bmc Gastroenterology 12.
27. Said EA, Al-Reesi I, Al-Riyami M, Al-Naamani K, Al-Sinawi S, Al-Balushi MS, et al. (2016) A Potential Inhibitory Profile of Liver CD68(+) Cells during HCV Infection as Observed by an Increased CD80 and PD-L1 but Not CD86 Expression. Plos One 11.
28. Gadd VL, Skoien R, Powell EE, Fagan KJ, Winterford C, Horsfall L, et al. (2014) The Portal Inflammatory Infiltrate and Ductular Reaction in Human Nonalcoholic Fatty Liver Disease. Hepatology 59: 1393-1405. doi: 10.1002/hep.26937 PMID: 24254368
29. Li H, Zheng HW, Chen H, Xing ZZ, You H, Cong M, et al. (2012) Hepatitis B virus particles preferably induce Kupffer cells to produce TGF-beta 1 over pro-inflammatory cytokines. Digestive and Liver Disease 44: 328-333. doi: 10.1016/j.dld.2011.11.005 PMID: 22177317
30. Burgio VL, Ballardini G, Artini M, Caratozzolo M, Bianchi FB, Levrero M (1998) Expression of co-stimulatory molecules by Kupffer cells in chronic hepatitis of hepatitis C virus etiology. Hepatology 27: 1600-1606. PMID: 9620333
31. Gadd VL, Melino M, Roy S, Horsfall L, O'Rourke P, Williams MR, et al. (2013) Portal, but not lobular, macrophages express matrix metalloproteinase-9: association with the ductular reaction and fibrosis in chronic hepatitis C. Liver International 33: 569-579. doi: 10.1111/liv.12050 PMID: 23240894
32. Kong LQ, Zhu XD, Xu HX, Zhang JB, Lu L, Wang WQ, et al. (2013) The Clinical Significance of the CD163+and CD68+Macrophages in Patients with Hepatocellular Carcinoma. Plos One 8.
33. Sigal SH, Ala A, Ivanov K, Hossain S, Bodian C, Schiano TD, et al. (2005) Histopathology and clinical correlates of end-stage hepatitis B cirrhosis: A possible mechanism to explain the response to antiviral therapy. Liver Transplantation 11: 82-88. PMID: 15690540
34. Cheng JD, Imanishi H, Morisaki H, Liu WD, Nakamura H, Morisaki T, et al. (2005) Recombinant HBsAg inhibits LPS-induced COX-2 expression and IL-18 production by interfering with the NF kappa B pathway in a human monocytic cell line, THP-1. Journal of Hepatology 43: 465-471. PMID: 15963597
35. Kondo Y, Ueno Y, Shimosegawa T (2011) Toll-Like Receptors Signaling Contributes to Immunopathogenesis of HBV Infection. Gastroenterology Research and Practice.
36. Khorramdelazad H, Hassanshahi G, Ahmadabadi BN, Arababadi MK (2012) High Serum Levels of TGF-beta in Iranians With Chronic HBV Infection. Hepatitis Monthly 12.
37. Sakai Y, Masamune A, Satoh A, Yamagiwa T, Shimosegawa T (2001) Serum and ascitic levels of macrophage migration inhibitory factor (MIF) are increased in severe acute pancreatitis. Gastroenterology 120: A469-A469.
38. Ding L, Linsley PS, Huang LY, Germain RN, Shevach EM (1993) Il-10 Inhibits Macrophage Costimulatory Activity by Selectively Inhibiting the up-Regulation of B7 Expression. Journal of Immunology 151: 1224-1234.
39. Mittal SK, Cho KJ, Ishido S, Roche PA (2015) Interleukin 10 (IL-10)-mediated Immunosuppression: MARCH-I INDUCTION REGULATES ANTIGEN PRESENTATION BY MACROPHAGES BUT NOT DENDRITIC CELLS. Journal of Biological Chemistry 290: 27158-27167. doi: 10.1074/jbc.M115.682708 PMID: 26408197
40. Fishman M, Hunter TB, Soliman H, Thompson P, Dunn M, Smilee R, et al. (2008) Phase II trial of B7-1 (CD-86) transduced, cultured autologous tumor cell vaccine plus subcutaneous interleukin-2 for treatment of stage IV renal cell carcinoma. Journal of Immunotherapy 31: 72-80. PMID: 18157014
41. Mclellan AD, Starling GC, Williams LA, Hock BD, Hart DNJ (1995) Activation of Human Peripheral-Blood Dendritic Cells Induces the Cd86 Costimulatory Molecule. European Journal of Immunology 25: 2064-2068. PMID: 7542604
42. Olesch C, Sha WX, Angioni C, Sha LK, Acaf E, Patrignani P, et al. (2015) MPGES-1-derived PGE2 suppresses CD80 expression on tumor-associated phagocytes to inhibit anti-tumor immune responses in breast cancer. Oncotarget 6: 10284-10296. PMID: 25871398
43. Cheng ASL, Chan HLY, Leung WK, To KF, Go MYY, Chan JYH, et al. (2004) Expression of HBx and COX-2 in chronic hepatitis B, cirrhosis and hepatocellular carcinoma: implication of HBx in upregulation of COX-2. Modern Pathology 17: 1169-1179. PMID: 15218507
44. Liu MF, Li JS, Weng TH, Lei HY (1999) Differential expression and modulation of costimulatory molecules CD80 and CD86 on monocytes from patients with systemic lupus erythematosus. Scandinavian Journal of Immunology 49: 82-87. PMID: 10023862
45. Akcam FZ, Tigli A, Kaya O, Ciris M, Vural H (2012) Cytokine Levels and Histopathology in Chronic Hepatitis B and Chronic Hepatitis C. Journal of Interferon and Cytokine Research 32: 570-574. doi: 10.1089/jir.2012.0048 PMID: 23067363
46. Zakaria S, El-Sisi A (2016) Rebamipide retards CCl4-induced hepatic fibrosis in rats: Possible role for PGE2. Journal of Immunotoxicology: 1-10.
47. Zajac E, Schweighofer B, Kupriyanova TA, Juncker-Jensen A, Minder P, Quigley JP, et al. (2013) Angiogenic capacity of M1-and M2-polarized macrophages is determined by the levels of TIMP-1 complexed with their secreted proMMP-9. Blood 122: 4054-4067. doi: 10.1182/blood-2013-05-501494 PMID: 24174628
48. Zimmermann HW, Seidler S, Gassler N, Nattermann J, Luedde T, Trautwein C, et al. (2011) Interleukin-8 Is Activated in Patients with Chronic Liver Diseases and Associated with Hepatic Macrophage Accumulation in Human Liver Fibrosis. Plos One 6.
49. Yang K, Guan SH, Zhang H, Pan Y, Wu YY, Wang AH, et al. (2014) Enhanced Levels of Interleukin-8 Are Associated with Hepatitis B Virus Infection and Resistance to Interferon-Alpha Therapy. International Journal of Molecular Sciences 15: 21286-21298. doi: 10.3390/ijms151121286 PMID: 25407531
50. Almajhdi FN, Al-Ahdal M, Abdo AA, Sanai FM, Al-Anazi M, Khalaf N, et al. (2013) Single nucleotide polymorphisms in CXCR1 gene and its association with hepatitis B infected patients in Saudi Arabia. Annals of Hepatology 12: 220-227. PMID: 23396733